437 related articles for article (PubMed ID: 8183370)
1. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM; Oltvai ZN; Korsmeyer SJ
Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
[TBL] [Abstract][Full Text] [Related]
2. Bax-independent inhibition of apoptosis by Bcl-XL.
Cheng EH; Levine B; Boise LH; Thompson CB; Hardwick JM
Nature; 1996 Feb; 379(6565):554-6. PubMed ID: 8596636
[TBL] [Abstract][Full Text] [Related]
3. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
Gurudutta GU; Verma YK; Singh VK; Gupta P; Raj HG; Sharma RK; Chandra R
FEBS Lett; 2005 Jul; 579(17):3503-7. PubMed ID: 15949801
[TBL] [Abstract][Full Text] [Related]
4. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
Zha H; Aimé-Sempé C; Sato T; Reed JC
J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
[TBL] [Abstract][Full Text] [Related]
5. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
Boyd JM; Gallo GJ; Elangovan B; Houghton AB; Malstrom S; Avery BJ; Ebb RG; Subramanian T; Chittenden T; Lutz RJ
Oncogene; 1995 Nov; 11(9):1921-8. PubMed ID: 7478623
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
7. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family.
Akahani S; Nangia-Makker P; Inohara H; Kim HR; Raz A
Cancer Res; 1997 Dec; 57(23):5272-6. PubMed ID: 9393748
[TBL] [Abstract][Full Text] [Related]
9. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
[TBL] [Abstract][Full Text] [Related]
11. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region.
Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A
Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomics: the evolutionary history of the Bcl-2 family.
Lanave C; Santamaria M; Saccone C
Gene; 2004 May; 333():71-9. PubMed ID: 15177682
[TBL] [Abstract][Full Text] [Related]
13. Regulators of cell death.
Korsmeyer SJ
Trends Genet; 1995 Mar; 11(3):101-5. PubMed ID: 7732571
[TBL] [Abstract][Full Text] [Related]
14. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.
Sedlak TW; Oltvai ZN; Yang E; Wang K; Boise LH; Thompson CB; Korsmeyer SJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7834-8. PubMed ID: 7644501
[TBL] [Abstract][Full Text] [Related]
15. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
[TBL] [Abstract][Full Text] [Related]
16. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
[TBL] [Abstract][Full Text] [Related]
18. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
Mei Y; Du W; Yang Y; Wu M
Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
Schmitt E; Paquet C; Beauchemin M; Bertrand R
Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
[TBL] [Abstract][Full Text] [Related]
20. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2.
Hengartner MO; Horvitz HR
Nature; 1994 May; 369(6478):318-20. PubMed ID: 7910376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
